C-Met Modulators and Methods of Use
US-2015376133-A1 · Dec 31, 2015 · US
US9061997B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9061997-B2 |
| Application number | US-201113885089-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 15, 2011 |
| Priority date | Nov 16, 2010 |
| Publication date | Jun 23, 2015 |
| Grant date | Jun 23, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to compounds which are quinolinone derivatives of general formula (I) capable of modulating the activity, in particular of inducing the differentiation, of stem and progenitor cells; these compounds are of use in the treatment of disorders related to a stem differentiation defect; the invention also relates to novel compounds among these quinolinone derivatives and to pharmaceutical compositions containing the same.
Opening claim text (preview).
The invention claimed is: 1. A method for the treatment of diseases caused by one or more of the dysregulation of osteoblast function or differentiation, or by a functional imbalance between osteoblasts and osteoclasts, the method causing inducement of cellular differentiation of stem or progenitor cells, said method comprising the step of administering a compounds of general formula (I):…
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.